✦ LIBER ✦

PMH27 COST-EFFECTIVENESS OF DULOXETINE VS. VENLAFAXINE XRAND SSRIS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN PRIMARY AND SECONDARY CARE IN SPAIN

✍ Scribed by E De Cock; Á Benedict; TK Le; JA Sacristán del Castillo; T Dilla

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH45 COST EFFECTIVENESS OF DULOXETINE C

✍ M Van Baardewijk; PM Vis; T Einarson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH84 PREDICTORS OFTREATMENT INITIATION

✍ W Ye; Y Zhao; R Swindle; RL Robinson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PMH27 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ Kulp, W; Greiner, W; Schulenburg, JM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PMH46 TREATMENT PERSISTENCE WITH DULOXET

✍ X Liu; P Tepper; CD Mullins 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PMH13 ASSOCIATION OF MEDICATION PERSISTE

✍ Liu, X; Tepper, P; Mullins, CD; Faries, D; Johnstone, B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH13 Longitudinal Analysis of Patient L

✍ Z. Cui; D.E. Faries; W. Shen; S.L. Able; D. Novick 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB